| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 4 | NIH | 1/26/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = -$141 ) |
| | 2022 | 2021 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 001 | 4 | NIH | 3/29/2022 | $0 |
| | 2022 | 2021 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 4 | NIH | 10/22/2021 | $0 |
| | 2022 | 2018 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R43AI125134 | Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia | 001 | 2 | NIH | 6/29/2022 | -$141 |
| | 2022 | 2017 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R43AI125134 | Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia | 000 | 1 | NIH | 6/29/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $952,100 ) |
| | 2021 | 2021 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 001 | 4 | NIH | 9/17/2021 | $952,100 |
| | 2021 | 2020 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 3 | NIH | 3/29/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,018,001 ) |
| | 2020 | 2020 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 001 | 3 | NIH | 7/24/2020 | $2,022,100 |
| | 2020 | 2018 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R43AI125134 | Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia | 000 | 2 | NIH | 7/6/2020 | -$4,099 |
| | 2020 | 2017 | PLATELET BIOGENESIS, INC. | 65 GROVE ST STE 303 | WATERTOWN | MA | 02472-2826 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 2 | NIH | 4/2/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | PLATELET BIOGENESIS, INC. | 325 VASSAR ST # 2A | CAMBRIDGE | MA | 02139-4818 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 2 | NIH | 4/3/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $300,000 ) |
| | 2018 | 2018 | PLATELET BIOGENESIS, INC. | 100 MORRISSEY BLVD WHEATLEY HALL FL 3 | BOSTON | MA | 02125-3300 | SUFFOLK | USA | R43AI125134 | Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia | 000 | 2 | NIH | 12/28/2017 | $300,000 |
| | 2018 | 2016 | PLATELET BIOGENESIS, INC. | 325 VASSAR ST # 2A | CAMBRIDGE | MA | 02139-4818 | MIDDLESEX | USA | SB1HL137591 | Development of an intellectual property (IP) strategy for the commercial advancement of a Direct Phase II SBIR-funded human platelet bioreactor | 000 | 1 | NIH | 12/21/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,029,375 ) |
| | 2017 | 2017 | PLATELET BIOGENESIS, INC. | 257 BONAD RD | CHESTNUT HILL | MA | 02467-3641 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 2 | NIH | 3/24/2017 | $729,375 |
| | 2017 | 2017 | PLATELET BIOGENESIS, INC. | 257 BONAD RD | CHESTNUT HILL | MA | 02467-3641 | MIDDLESEX | USA | R43AI125134 | Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia | 000 | 1 | NIH | 1/4/2017 | $300,000 |
|
| Issue Date FY: 2016 ( Subtotal = $779,375 ) |
| | 2016 | 2016 | PLATELET BIOGENESIS, INC | 257 BONAD RD | CHESTNUT HILL | MA | 02467-3641 | MIDDLESEX | USA | SB1HL137591 | Development of an intellectual property (IP) strategy for the commercial advancement of a Direct Phase II SBIR-funded human platelet bioreactor | 000 | 1 | NIH | 9/24/2016 | $50,000 |
| | 2016 | 2016 | PLATELET BIOGENESIS, INC | 257 BONAD RD | CHESTNUT HILL | MA | 02467-3641 | MIDDLESEX | USA | R44HL131050 | PLT+ Characterization and IND-Enabling Studies | 000 | 1 | NIH | 2/19/2016 | $729,375 |
|
|
